July 2017 ENCALS statement on edaravone

Ammar Al-Chalabi, Peter M. Andersen, Siddharthan Chandran, Adriano Chio, Philippe Corcia, Philippe Couratier, Olof Danielsson, Mamede de Carvalho, Claude Desnuelle, Torsten Grehl, Julian Grosskreutz, Trygve Holmøy, Caroline Ingre, Merete Karlsborg, Grethe Kleveland, Jan Christoph Koch, Blaz Koritnik, Magdalena KuzmaKozakiewicz, Hannu Laaksovirta, Albert C LudolphChristopher J Mcdermott, Thomas Meyer, Bernardo Mitre Ropero, Jesus Mora Pardina, Ingela Nygren, Susanne Petri, Mónica Povedano Panades, Francois Salachas, Pamela J Shaw, Vincenzo Silani, Gert Staaf, Kirsten Svenstrup, Kevin Talbot, Ole-Bjørn Tysnes, Philip Van Damme, Anneke J. van der Kooi, Markus Weber, Patrick Weydt, Joachim Wolf, Orla Hardiman, Leonard H van den Berg

Research output: Contribution to journalReview articlepeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)471-474
Number of pages4
JournalAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Volume18
Issue number7-8
Early online date2017
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Journal Article
  • Antipyrine/analogs & derivatives
  • Humans
  • Amyotrophic Lateral Sclerosis/drug therapy
  • Decision Making/physiology
  • Treatment Outcome
  • Free Radical Scavengers/therapeutic use
  • Edaravone

Cite this